theophylline has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Theophylline treatment suppressed IL-17 production through inhibiting cytokines controlling Th17 differentiation; TGF-β, IL-6, IL-1β, and IL-23." | 1.91 | Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation. ( Hahn, HJ; Lee, HJ; Oh, SR; Park, SJ, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SJ | 1 |
| Hahn, HJ | 1 |
| Oh, SR | 1 |
| Lee, HJ | 1 |
1 other study available for theophylline and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation.
Topics: Animals; Bleomycin; Cell Differentiation; Idiopathic Pulmonary Fibrosis; Interleukin-6; Lung; Mice; | 2023 |